Dr Agarwals Eye Hospital
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Dr. Agarwal’s Eye Hospital is strategically positioned to leverage the anticipated growth in the Indian eye care market, with management emphasizing operational efficiency and network expansion as key priorities. The recent amalgamation with Dr. Agarwal’s Health Care Limited is expected to enhance market presence and streamline operations, which aligns with Vista's forecast of stable margins and moderated revenue growth. Despite the competitive landscape and capital-intensive nature of the business, management's focus on technology-led clinical excellence and disciplined cost management supports a long-term growth outlook. However, the healthcare sector faces challenges, including projected declines in EBITDA margins and inflationary pressures that could impact operational efficiency. Overall, Vista's financial outlook reflects a cautious stance, with a strong sell recommendation based on expected downside risks. Over the next 12-24 months, opportunities include the growing demand for organized healthcare services and increasing insurance coverage, while headwinds consist of competitive pressures and potential supply disruptions. The company’s ability to navigate these dynamics will be critical in determining its future performance
Why We Like This Stock
- Strategic amalgamation with Dr. Agarwal’s Health Care Limited expected to enhance operational efficiency and market presence
- Strong brand equity and focus on specialized eye care provide a competitive advantage in a growing market
- Management's commitment to technology-led clinical excellence supports long-term value creation
Things To Watch Out For
- Projected declines in EBITDA margins due to competitive pressures and inflationary impacts
- Capital-intensive growth strategy may strain financial resources in a challenging economic environment
- Navigating a fragmented market with increasing competition from government healthcare institutions
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 319 | 397 | 471 | 500 | 573 |
| Profit Before Tax (Cr.) | 62 | 70 | 94 | 102 | 116 |
| PBT Margin | 19.5% | 17.7% | 20.0% | 20.3% | 20.2% |
| Net Profit (Cr.) | 64 | 64 | 70 | 76 | 87 |
| Earnings Per Share | 2.0 | 2.0 | 2.2 | 2.4 | 2.7 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, pinhole pupilloplasty, rosette cataract, and congenital glaucoma. It also operates opticals and pharmacies and is engaged in the sale of optical frames, contact lenses, accessories, and pharmaceutical products. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited operates as a subsidiary of Dr. Agarwal's Health Care Limited.